Gentex CorporationGNTXNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank38
3Y CAGR-35.2%
5Y CAGR-28.7%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-35.2%/yr
vs +3.9%/yr prior
5Y CAGR
-28.7%/yr
Recent deceleration
Acceleration
-39.2pp
Decelerating
Percentile
P38
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.13% |
| Q3 2025 | 2.26% |
| Q2 2025 | 12.08% |
| Q1 2025 | -2.42% |
| Q4 2024 | -2.41% |
| Q3 2024 | 9.59% |
| Q2 2024 | 4.32% |
| Q1 2024 | 1.56% |
| Q4 2023 | 3.33% |
| Q3 2023 | 5.86% |
| Q2 2023 | 9.58% |
| Q1 2023 | -0.81% |
| Q4 2022 | 4.16% |
| Q3 2022 | 2.08% |
| Q2 2022 | 2.76% |
| Q1 2022 | 2.15% |
| Q4 2021 | 5.21% |
| Q3 2021 | 2.38% |
| Q2 2021 | 5.09% |
| Q1 2021 | -6.31% |
| Q4 2020 | 6.12% |
| Q3 2020 | -4.07% |
| Q2 2020 | -2.10% |
| Q1 2020 | 2.69% |
| Q4 2019 | -1.90% |
| Q3 2019 | 3.67% |
| Q2 2019 | 0.96% |
| Q1 2019 | 4.05% |
| Q4 2018 | 0.40% |
| Q3 2018 | -1.15% |
| Q2 2018 | 4.42% |
| Q1 2018 | 6.06% |
| Q4 2017 | -0.85% |
| Q3 2017 | -1.87% |
| Q2 2017 | 0.36% |
| Q1 2017 | 2.70% |
| Q4 2016 | 3.84% |
| Q3 2016 | 2.22% |
| Q2 2016 | -0.08% |
| Q1 2016 | 0.46% |